Compare Biogen Inc (BIIB) vs MINISO Group Holding Ltd (MNSO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Biogen Inc vs MINISO Group Holding Ltd — how do they compare? Biogen Inc trades at $191.95 (market cap $30.86B), while MINISO Group Holding Ltd trades at $12.41 (market cap $3.41B). The key difference: Biogen Inc is far larger — about 9× MINISO Group Holding Ltd's market cap, and MINISO Group Holding Ltd pays a 5.83% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | MNSO | |
|---|---|---|
Market Cap | $30.86B | $3.41B |
Sector | Health | Technology |
52-Week High | $216.63 | $26.63 |
52-Week Low | $122.68 | $11.30 |
Enterprise Value | $33.14B | $4.08B |
Dividend Yield | — | 5.83% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →About MINISO Group Holding Ltd
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →
